Companies / Russia
36.6 Buys Rivals
February 2007 | Company News AlertTo maintain its leading position in the Russian retail pharmaceutical market and expand its reach, domestic pharmacy chain 36.6 has revealed that it purchased several smaller rivals during Q406. BMI is not surprised at the acquisitive strategy of 36.6 given its history, and expects the firm's competitors - such as Rigla - to make similar acquisitions to remain competitive.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.




